Cargando…
P772: LONG-TERM RAVULIZUMAB TREATMENT IN COMPLEMENT INHIBITOR-EXPERIENCED PATIENTS WITH PNH PROVIDES DURABLE CONTROL OF INTRAVASCULAR HEMOLYSIS WITH LOW INCIDENCE OF MAJOR ADVERSE VASCULAR EVENTS AND DEATH.
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430716/ http://dx.doi.org/10.1097/01.HS9.0000969992.63273.36 |
| _version_ | 1785091032925339648 |
|---|---|
| author | Kulasekararaj, Austin Brodsky, Robert Griffin, Morag Röth, Alexander Piatek, Caroline Ogawa, Masayo Yu, Ji Patel, Yogesh Fernandez, Fernando Ataulfo Gonzalez Nishimura, Jun-Ichi Peffault de Latour, Régis Szer, Jeff Wook Lee, Jong |
| author_facet | Kulasekararaj, Austin Brodsky, Robert Griffin, Morag Röth, Alexander Piatek, Caroline Ogawa, Masayo Yu, Ji Patel, Yogesh Fernandez, Fernando Ataulfo Gonzalez Nishimura, Jun-Ichi Peffault de Latour, Régis Szer, Jeff Wook Lee, Jong |
| author_sort | Kulasekararaj, Austin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430716 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104307162023-08-17 P772: LONG-TERM RAVULIZUMAB TREATMENT IN COMPLEMENT INHIBITOR-EXPERIENCED PATIENTS WITH PNH PROVIDES DURABLE CONTROL OF INTRAVASCULAR HEMOLYSIS WITH LOW INCIDENCE OF MAJOR ADVERSE VASCULAR EVENTS AND DEATH. Kulasekararaj, Austin Brodsky, Robert Griffin, Morag Röth, Alexander Piatek, Caroline Ogawa, Masayo Yu, Ji Patel, Yogesh Fernandez, Fernando Ataulfo Gonzalez Nishimura, Jun-Ichi Peffault de Latour, Régis Szer, Jeff Wook Lee, Jong Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430716/ http://dx.doi.org/10.1097/01.HS9.0000969992.63273.36 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Kulasekararaj, Austin Brodsky, Robert Griffin, Morag Röth, Alexander Piatek, Caroline Ogawa, Masayo Yu, Ji Patel, Yogesh Fernandez, Fernando Ataulfo Gonzalez Nishimura, Jun-Ichi Peffault de Latour, Régis Szer, Jeff Wook Lee, Jong P772: LONG-TERM RAVULIZUMAB TREATMENT IN COMPLEMENT INHIBITOR-EXPERIENCED PATIENTS WITH PNH PROVIDES DURABLE CONTROL OF INTRAVASCULAR HEMOLYSIS WITH LOW INCIDENCE OF MAJOR ADVERSE VASCULAR EVENTS AND DEATH. |
| title | P772: LONG-TERM RAVULIZUMAB TREATMENT IN COMPLEMENT INHIBITOR-EXPERIENCED PATIENTS WITH PNH PROVIDES DURABLE CONTROL OF INTRAVASCULAR HEMOLYSIS WITH LOW INCIDENCE OF MAJOR ADVERSE VASCULAR EVENTS AND DEATH. |
| title_full | P772: LONG-TERM RAVULIZUMAB TREATMENT IN COMPLEMENT INHIBITOR-EXPERIENCED PATIENTS WITH PNH PROVIDES DURABLE CONTROL OF INTRAVASCULAR HEMOLYSIS WITH LOW INCIDENCE OF MAJOR ADVERSE VASCULAR EVENTS AND DEATH. |
| title_fullStr | P772: LONG-TERM RAVULIZUMAB TREATMENT IN COMPLEMENT INHIBITOR-EXPERIENCED PATIENTS WITH PNH PROVIDES DURABLE CONTROL OF INTRAVASCULAR HEMOLYSIS WITH LOW INCIDENCE OF MAJOR ADVERSE VASCULAR EVENTS AND DEATH. |
| title_full_unstemmed | P772: LONG-TERM RAVULIZUMAB TREATMENT IN COMPLEMENT INHIBITOR-EXPERIENCED PATIENTS WITH PNH PROVIDES DURABLE CONTROL OF INTRAVASCULAR HEMOLYSIS WITH LOW INCIDENCE OF MAJOR ADVERSE VASCULAR EVENTS AND DEATH. |
| title_short | P772: LONG-TERM RAVULIZUMAB TREATMENT IN COMPLEMENT INHIBITOR-EXPERIENCED PATIENTS WITH PNH PROVIDES DURABLE CONTROL OF INTRAVASCULAR HEMOLYSIS WITH LOW INCIDENCE OF MAJOR ADVERSE VASCULAR EVENTS AND DEATH. |
| title_sort | p772: long-term ravulizumab treatment in complement inhibitor-experienced patients with pnh provides durable control of intravascular hemolysis with low incidence of major adverse vascular events and death. |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430716/ http://dx.doi.org/10.1097/01.HS9.0000969992.63273.36 |
| work_keys_str_mv | AT kulasekararajaustin p772longtermravulizumabtreatmentincomplementinhibitorexperiencedpatientswithpnhprovidesdurablecontrolofintravascularhemolysiswithlowincidenceofmajoradversevasculareventsanddeath AT brodskyrobert p772longtermravulizumabtreatmentincomplementinhibitorexperiencedpatientswithpnhprovidesdurablecontrolofintravascularhemolysiswithlowincidenceofmajoradversevasculareventsanddeath AT griffinmorag p772longtermravulizumabtreatmentincomplementinhibitorexperiencedpatientswithpnhprovidesdurablecontrolofintravascularhemolysiswithlowincidenceofmajoradversevasculareventsanddeath AT rothalexander p772longtermravulizumabtreatmentincomplementinhibitorexperiencedpatientswithpnhprovidesdurablecontrolofintravascularhemolysiswithlowincidenceofmajoradversevasculareventsanddeath AT piatekcaroline p772longtermravulizumabtreatmentincomplementinhibitorexperiencedpatientswithpnhprovidesdurablecontrolofintravascularhemolysiswithlowincidenceofmajoradversevasculareventsanddeath AT ogawamasayo p772longtermravulizumabtreatmentincomplementinhibitorexperiencedpatientswithpnhprovidesdurablecontrolofintravascularhemolysiswithlowincidenceofmajoradversevasculareventsanddeath AT yuji p772longtermravulizumabtreatmentincomplementinhibitorexperiencedpatientswithpnhprovidesdurablecontrolofintravascularhemolysiswithlowincidenceofmajoradversevasculareventsanddeath AT patelyogesh p772longtermravulizumabtreatmentincomplementinhibitorexperiencedpatientswithpnhprovidesdurablecontrolofintravascularhemolysiswithlowincidenceofmajoradversevasculareventsanddeath AT fernandezfernandoataulfogonzalez p772longtermravulizumabtreatmentincomplementinhibitorexperiencedpatientswithpnhprovidesdurablecontrolofintravascularhemolysiswithlowincidenceofmajoradversevasculareventsanddeath AT nishimurajunichi p772longtermravulizumabtreatmentincomplementinhibitorexperiencedpatientswithpnhprovidesdurablecontrolofintravascularhemolysiswithlowincidenceofmajoradversevasculareventsanddeath AT peffaultdelatourregis p772longtermravulizumabtreatmentincomplementinhibitorexperiencedpatientswithpnhprovidesdurablecontrolofintravascularhemolysiswithlowincidenceofmajoradversevasculareventsanddeath AT szerjeff p772longtermravulizumabtreatmentincomplementinhibitorexperiencedpatientswithpnhprovidesdurablecontrolofintravascularhemolysiswithlowincidenceofmajoradversevasculareventsanddeath AT wookleejong p772longtermravulizumabtreatmentincomplementinhibitorexperiencedpatientswithpnhprovidesdurablecontrolofintravascularhemolysiswithlowincidenceofmajoradversevasculareventsanddeath |